Therapeutic Drug Monitoring of Anti-Thymocyte Globulin in Allogeneic Stem Cell Transplantation: Proof of ConceptJoyce Meesters-Ensing, Stefan Nierkens, Caroline A. Lindemans et al.|Frontiers in Pharmacology|2022Cited by 19
IMMU-58. CHARACTERIZATION OF MYELOID CELL POPULATIONS IN PEDIATRIC HIGH-GRADE BRAIN TUMORS: THE MIMIC PROGRAMTiago Carvalheiro, Stefan Nierkens, Joyce Meesters-Ensing et al.|Neuro-Oncology|2023Cited by 0
IMMU-53. MONITOR THE IMMUNE MICROENVIRONMENT AND SYSTEMIC IMMUNE EFFECTS IN PEDIATRIC BRAIN TUMORS – THE MIMIC PROGRAMRaoull Hoogendijk, Jasper van der Lugt, Tiago Carvalheiro et al.|Neuro-Oncology|2023Cited by 0
IMMU-46. MONITORING T-CELL DYNAMICS AND CHECKPOINT EXPRESSION IN THE IMMUNE MICROENVIRONMENT OF PEDIATRIC HIGH GRADE BRAIN TUMORS: THE MIMIC PROGRAMJoyce Meesters-Ensing, Stefan Nierkens, Eelco W. Hoving et al.|Neuro-Oncology|2023Cited by 0
High Risk of GvHD in Children Transplanted for Refractory Cytopenia of Childhood: Importance of Sufficient Exposure to Anti-Thymocyte GlobulinEva Koopman-Coenen, Mirjam E. Belderbos, Joyce Meesters-Ensing et al.|Blood|2023Cited by 0